Castellano | Euskara | Français | English
DAR No 4: Tovedeso®. Desfesoterodine in syndrome overactive bladder
Share it
- DAR No 1: Reagila®. Cariprazine to treat schizophrenia
- DAR No 2: Latuda®. Lurasidone for schizophrenia
- DAR No 3: Steglatro®. Ertugliflozin for type 2 diabetes mellitus
- DAR No 4: Tovedeso®. Desfesoterodine in syndrome overactive bladder
- DAR No 5: Ozempic®. Semaglutida for type 2 diabetes mellitus
Making the fesoterodine profitable
Due to the absence of comparative studies and assimilate data of its prodrug fesoterodine, it is considered desfesoterodine does not imply an improvement over other urinary antispasmodics for treatment of overactive bladder syndrome
